Skip to main content

CORRECTION article

Front. Pharmacol., 30 November 2015
Sec. Neuropharmacology
Volume 6 - 2015 | https://doi.org/10.3389/fphar.2015.00285

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

This article is a correction to:

  1. Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

    1. Read original article
\r\nEduardo R. Butelman*Eduardo R. Butelman*Mary Jeanne KreekMary Jeanne Kreek
  • Laboratory on the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA

A corrigendum on
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

by Butelman, E. R., and Kreek, M. J. (2015) Front. Pharmacol. 6:190. doi: 10.3389/fphar.2015.00190

Reason for Corrigendum:

In the original review, we placed an incorrect citation in the following sentence:

“Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Whitfield et al., 2015).”

The correct sentence and citation are as follows:

“Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Freeman et al., 2014).”

The authors apologize for the mistake. This error does not change the scientific conclusions of the review.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Freeman, K. B., Naylor, J. E., Prisinzano, T. E., and Woolverton, W. L. (2014). Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology (Berl.) 231, 2751–2758. doi: 10.1007/s00213-014-3436-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: kappa-opioid receptor, dynorphins, salvinorin A, Salvia divinorum, depression, addiction

Citation: Butelman ER and Kreek MJ (2015) Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Front. Pharmacol. 6:285. doi: 10.3389/fphar.2015.00285

Received: 16 November 2015; Accepted: 16 November 2015;
Published: 30 November 2015.

Edited and reviewed by: George Panagis, University of Crete, Greece

Copyright © 2015 Butelman and Kreek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Eduardo R. Butelman, butelme@rockefeller.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.